000963 華東醫藥
按盤價 
27.310 +0.030 (+0.110%)
27.310 +0.030 (+0.110%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 22,066,646 | 1.81% | 43,612,010 | 41,905,707 | 40,623,783 | 37,714,587 | |
| 減：營業總成本 | 19,835,883 | 2.15% | 39,388,881 | 37,493,020 | 37,081,915 | 34,568,570 | |
| 其中:營業成本 | 14,828,934 | 3.50% | 29,499,479 | 27,988,547 | 27,461,732 | 25,682,497 | |
| 財務費用 | 15,815 | -29.47% | 18,773 | 22,265 | 51,190 | 78,257 | |
| 資產減值損失 | (7,889) | -- | (87,896) | (41,006) | (6,520) | (3,822) | |
| 公允價值變動收益 | -- | -- | -- | -- | (13,756) | 28,469 | |
| 投資收益 | 596 | -100.89% | (137,843) | (129,191) | (219,713) | (141,560) | |
| 其中：對聯營企業和合營企業的投資收益 | 28,392 | -180.28% | (75,923) | (68,453) | (188,391) | (115,619) | |
| 營業利潤 | 2,257,976 | 0.65% | 4,107,893 | 4,324,737 | 3,452,927 | 3,061,454 | |
| 利潤總額 | 2,210,993 | 0.81% | 4,016,462 | 4,301,514 | 3,465,986 | 3,031,124 | |
| 減：所得稅費用 | 371,104 | -4.80% | 605,616 | 807,328 | 619,589 | 498,499 | |
| 淨利潤 | 1,839,890 | 2.03% | 3,410,847 | 3,494,186 | 2,846,397 | 2,532,626 | |
| 減：非控股權益 | (20,868) | 81.49% | (3,489) | (17,919) | 7,536 | 33,411 | |
| 股東淨利潤 | 1,860,757 | 2.53% | 3,414,335 | 3,512,105 | 2,838,861 | 2,499,214 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.061 | 3.08% | 1.948 | 2.005 | 1.622 | 1.428 | |
| 每股派息 (元) * | 0.350 | 0.00% | 0.930 | 0.930 | 0.580 | 0.290 | |
| 每股淨資產 (元) * | 14.507 | 7.13% | 14.145 | 13.145 | 11.997 | 10.592 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 26/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
